Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Oct 30, 2025
- Accession no.
- 0001106578-25-000024
- Filed
- Oct 30, 2025
- Trade date
- Oct 27-28, 2025
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.32M. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 27, 2025 | Common Stock | MOption exerciseAcquired | +4,000 | $120.26 | +$481,040 | 4,130 | Direct | |
| Oct 27, 2025 | Common Stock | SSaleDisposed | −1,000 | $411.95F2 | −$411,950 | 3,130 | Direct | |
| Oct 27, 2025 | Common Stock | SSaleDisposed | −1,814 | $414.42F3 | −$751,757.88 | 1,316 | Direct | |
| Oct 27, 2025 | Common Stock | SSaleDisposed | −1,186 | $420.29F4 | −$498,463.94 | 130 | Direct | |
| Oct 28, 2025 | Common Stock | MOption exerciseAcquired | +4,000 | $120.26 | +$481,040 | 4,130 | Direct | |
| Oct 28, 2025 | Common Stock | SSaleDisposed | −1,991 | $413.58F5 | −$823,437.78 | 2,139 | Direct | |
| Oct 28, 2025 | Common Stock | SSaleDisposed | −509 | $415.02 | −$211,245.18 | 1,630 | Direct | |
| Oct 28, 2025 | Common Stock | SSaleDisposed | −1,500 | $417.92F6 | −$626,880 | 130 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 27, 2025 | Common Stock | MOption exerciseDisposed | −4,000 | $0.00 | $0 | 150,000 | Direct | |
| Oct 28, 2025 | Common Stock | MOption exerciseDisposed | −4,000 | $0.00 | $0 | 146,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $411.92 to $412.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $414.02 to $414.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $420.04 to $420.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $413.15 to $413.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $417.705 to $418.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.